Kishbauch Michael D
SEC-identified person · CIK 1076979 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Catabasis Pharmaceuticals INC CATB | Director | filed 2016 - 2026 |
| Achillion Pharmaceuticals INC ACHN | Director · CEO and President | filed 2006 - 2020 |
| Progenics Pharmaceuticals INC PGNX | Director | filed 2013 - 2019 |
| Tetralogic Pharmaceuticals Corp TLOG | Director | filed 2014 - 2015 |
| Ariad Pharmaceuticals INC ARIA | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.